• no-js

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases.

The Institute values communication with members of the broader scientific community and the general public and with the support of the MRC we have commissioned three short videos to explain our mission.

News

CNRS-Oxford Collaboration Scheme Grant Awarded

CNRS-Oxford Collaboration Scheme Grant Awarded

Posted 17/10/2014

David Clynes, a post-doctoral scientist in Richard Gibbons' lab, has successfully been awarded a grant through the CNRS-Oxford Collaboration scheme.  The scheme aims to facilitate the development of new collaborations, between researchers at the two organisations.  David will use the funding to visit the Almouzni laboratory in Paris with the collaborative aim to study the dynamics of ATRX mediated histone deposition. Of the award, David said ...

 

Leukaemia and Lymphoma Research Grant Awarded

Leukaemia and Lymphoma Research Grant Awarded

Posted 10/10/2014

Prof Paresh Vyas has just been awarded a Grant from Leukaemia and Lymphoma Research  - A first-in-human, first-in-class Phase I dose escalation trial of Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Acute Myeloid Leukaemia (AML). Paresh says – “Leukaemia and Lymphoma Research is one of the biggest charitable funders of haematology research in the UK.  They have awarded the MRC Molecular Haematology Unit a grant of £300 000 to ...

 News Archive

 

Vacancies

Personnel and Administration Assistant ref 115593

Posted 17/10/2014

Grade 4: £20,781 - £24,057 with a discretionary range to £26,274 p.a. We are looking for a proactive and committed individual to join our Personnel and Administration team, to predominantly support the recruitment and pre-employment process. Duties will include maintaining the CoreHR system throughout the recruitment process, generating documentation and arranging interviews, complying with employment legislation and University procedures ...

Further Vacancies

WIMM Blog

From petri dish to personalised medicine

From petri dish to personalised medicine

Posted 08/10/2014

From petri dish to personalised medicine Bowel cancer is one of the most common forms of cancer. In 2011, over 40,000 people in the UK were diagnosed with the disease1: equivalent to one person every 15 minutes2. In order to try and understand how and why this form of cancer develops, scientists need to be able to grow cells derived from tumours in the lab – something which has proven to be extremely challenging. However, researchers in ...

WIMM Blog Archive